These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 396054)

  • 21. Observations on praziquantel against Schistosoma haematobium.
    McMahon JE
    Arzneimittelforschung; 1981; 31(3a):579-80. PubMed ID: 7195249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials with praziquantel in schistosomiasis mansoni.
    Katz N; Rocha RS; Chaves A
    Rev Inst Med Trop Sao Paulo; 1981; 23(2):72-8. PubMed ID: 7025168
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of urinary and intestinal bilharziosis with praziquantel. Apropos of 182 cases].
    Gentilini M; Brucker G; Danis M; Mogahed A; Datry A
    Bull Soc Pathol Exot Filiales; 1982 Nov; 75(5):523-9. PubMed ID: 7165900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel.
    Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1981 Sep; 12(3):413-7. PubMed ID: 7342331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity of S. intercalatum to praziquantel (author's transl)].
    Deniau M; Eben Moussi E; Same Ekobo A; Ripert C
    Med Trop (Mars); 1981; 41(6):657-9. PubMed ID: 7339424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hepatosplenic Schistosomiasis mansoni with praziquantel. Preliminary report on tolerance and efficacy.
    Coutinho A; Domingues AL; Neves J; Almeida ST
    Arzneimittelforschung; 1983; 33(5):787-91. PubMed ID: 6683560
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.
    Scherrer AU; Sjöberg MK; Allangba A; Traoré M; Lohourignon LK; Tschannen AB; N'Goran EK; Utzinger J
    Acta Trop; 2009 Mar; 109(3):226-31. PubMed ID: 19070583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Praziquantel in the treatment of schistosomiasis mansoni in children].
    Emanuel A; Prata A
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):178-81. PubMed ID: 6361967
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of praziquantel on Schistosoma haematobium, S. japonicum and S. mansoni in primates.
    Webbe G; James C; Nelson GS; Sturrock RF
    Arzneimittelforschung; 1981; 31(3a):542-4. PubMed ID: 7195244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further experience with praziquantel in schistosoma japonicum infections.
    Fu FY; Zheng JS; Chen WQ; Qin KS; Jin MY; Liu X; Wang QL; Lu SC
    Chin Med J (Engl); 1984 Jan; 97(1):47-52. PubMed ID: 6428832
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium).
    Kern P; Burchard GD; Dietrich M
    Tropenmed Parasitol; 1984 Jun; 35(2):95-9. PubMed ID: 6464192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment with praziquantel of schistosomiasis carriers in an endemic area, with persistent positivity after successive administration of oxamniquine].
    de Camargo S
    Rev Inst Med Trop Sao Paulo; 1982; 24(3):180-7. PubMed ID: 6760351
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of praziquantel therapy on the histopathological and parasitological aspects of experimental schistosomiasis mansoni.
    El-Hawey A; Masoud A; Metwally A; El Badrawy N; El Garam A; Roushdi M; Khalil A
    J Egypt Soc Parasitol; 1983 Dec; 13(2):613-24. PubMed ID: 6663121
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of praziquantel against Schistosoma mansoni-infections in Botswana.
    Friis H; Byskov J
    Trop Geogr Med; 1989 Jan; 41(1):49-51. PubMed ID: 2503911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection.
    Pungpak S; Bunnag D; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):248-52. PubMed ID: 3906918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences with praziquantel against Schistosoma japonicum infection in the Philippines.
    Noseñas JS; Santos AT; Blas BL; Tormis LC; Portillo GP; Poliquit OS; Papasin MC; Flores GS
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):489-97. PubMed ID: 6398917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.